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Background 
Based on cost-effectiveness considerations and on 
the risk of nosocomial transmission of Mycobacterium 
tuberculosis strains, the World Health Organization 
(WHO) and other international institutions recommend 
to minimize unnecessary hospitalization of 
tuberculosis (TB) cases [1,2,3,4]. 
As in other Former Soviet Union (FSU) countries, 
the organisations of TB services in Armenia are 
heavily based on vertical and specialized services. 
In Armenia, a country of 3.2 million inhabitants, 
TB is one of the major public health problems with 
overall notification and estimated mortality rates of 41 
and 8.8 cases per 100,000 population in 2011, 
respectively [5,6]. The prevalence of multidrug-
resistant (MDR-TB) was 9.4% and 43.2% among new 
and previously treated cases, respectively, with 11.9% 
of them estimated to be extensively drug-resistant 
(XDR-TB) [6,7]. 
Specialized TB services include 9 in-patient TB 
departments, 73 out-patient TB units (called TB 
cabinets) based in general health-care facilities, and 31 
laboratories providing sputum smear microscopy, 
while culture and drug susceptibility testing is 
performed in the National TB Reference Laboratory. 
Following WHO recommendations, the Armenian 
National TB Programme (NTP) expanded the basic 
package of services provided in out-patient settings, 
allowing free access/free of charge TB diagnosis and 
treatment to the population, to achieve the global TB 
targets in the WHO European Region under the 
National Strategic Plan 2007-2015 and Consolidated 
Action Plan to Prevent and Combat M/XDR-TB in the 
WHO European Region 2011-2015 [8]. 
Despite programme success in reducing the default 
rate of new sputum smear-positive pulmonary TB 
patients from 14% to 7% in five years, the treatment 
success rate (72% in 2011) of the diagnosed cases is 
far below WHO targets [6]. The main shortcomings 
identified by the WHO Programme Review conducted 
in 2011 [7] include an alarming prevalence of 
M/XDR-TB, suggesting that directly observed therapy 
(DOT) is not systematically applied. An analysis of 
risk factors for MDR-TB in Armenia proved that after 
completion of the hospital phase of treatment, a 
relevant proportion of patients (6.1%; 8/133) interrupts 
treatment during the ambulatory phase, with less than 
30% of them undergoing DOT [9]. 
In addition, TB case detection for new sputum 
smear-positive pulmonary TB patients remains as low 
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as 27%. To improve programme performance and 
expand patient-centered approaches, it is important to 
strengthen outpatient services to improve TB detection 
and treatment adherence in Armenia. For the above-
mentioned reasons, the WHO Programme Review has 
begun to promote ambulatory diagnosis and treatment 
for TB patients to reduce unnecessary hospitalizations 
and excessive costs [7]. 
The costs of the TB services, such as staff salaries, 
in-patient and ambulatory care costs, are largely 
covered by the government, with most of the health 
expenditure represented by recurrent costs (96.7% in 
2011) versus capital costs (3.3%) [9]. The Global Fund 
supports diagnosis and treatment to manage M/XDR-
TB cases. 
The current funding scheme for hospital-based 
care for TB relies on bed occupancy/days. The cost of 
one bed per day in 2012 was 8,900 Armenian Drams 
(AMD) (≈20 €), while the cost of one TB cabinet visit 
is about 5.6 times cheaper (about 1,600 AMD ≈ 3 €) 
[10]. 
The refund related to the out-patient activities is 
fixed, based on the catchment population of the 
facility, so that staff is not motivated to increase the 
daily number of medical visits. In other words, 
physicians, receiving a fixed salary, are not 
encouraged to manage TB cases in an out-patient 
setting, and prefer to refer them for admission. As a 
consequence, 80% of the TB case-load is absorbed by 
the in-patient system against 20% managed by the 
ambulatory system. Unfortunately, this mechanism 
creates an unfair competition for resources between 
the “old” hospital-centred and the “new” patient-
centred model. The Ministry of Health is considering 
the options to revise the funding mechanism for TB 
services; however, no changes have been instituted as 
of today. 
The aims of the present study are to 1) evaluate the 
effect of maintaining the present funding scheme 
based on in- versus out-patient management, and 2) 
estimate the savings that might be achieved limiting 
the unnecessary hospitalizations of non-infectious 




A retrospective analysis of monitoring and 
evaluating data from the newly implemented NTP 
electronic database was performed using national data 
for 2011 and 2012 (first six months). 
In addition to quarterly routine recording and 
reporting notifications, a standard questionnaire used 
by TB supervisors during their monitoring visits to 
document referral to hospital-based care and in- versus 
out-patient management was analyzed. Indicators of 
TB care management (2011 versus 2012) were 
calculated and compared using Epi Info 7 statistical 




A consistent number of TB suspects is still 
referred to in-patient departments for diagnosis 
(1,450/4,389; 33% versus 668/1,939; 34.5%) with no 
statistically significant differences between 2011 and 
2012 (p = 0.44), while the proportion of TB cases 
detected among all TB suspects referred to in-patient 
departments for diagnosis slightly decreased 
(551/1,450; 38% versus 234/668; 35%; p = 0.4). 
The proportion of TB patients diagnosed in TB 
out-patient units out of the total number registered 
significantly decreased from 45.2% to 35.6% 
(527/1,165 versus 273/766; p < 0.001). Furthermore, 
63% of TB suspects referred for diagnosis to hospitals 
(1,333/2,118) in the study period were diagnosed as 
negative for TB. 
During the study period, the proportion of patients 
referred to hospitals to initiate their treatment was 97% 
for sputum smear-positive (n = 607) and 90% for 
sputum smear-negative and extra-pulmonary (n = 
1,755) patients. The proportion of sputum smear-
positive cases represented 25.7% (607/2,362) of the 
total number of registered cases; therefore, most of the 
hospitalized patients were sputum smear-negative and 
extra-pulmonary cases. 
The costs for a single day of hospital admission in 
Armenia (2012 costs; 2011 notification data)  and the 
potential savings that can be achieved for each day of 
inpatient management avoided (in favour of out-
patient management) are summarised in the Figure. 
With a feasible reduction of hospital admission of 75% 
of these cases, about 20,000 € might be saved every 
day, for a total of 7,260,945 € per year. 
 
Discussion 
The potential savings that Armenia can re-invest in 
the TB programme are significant. Established clinical 
traditions which are prevalent in FSU countries, such 
as hospitalising non-infectious TB cases for the 
intensive phase of treatment (2 months) and admitting 
TB suspects for further investigations, do not comply 
with international recommendations, and pose 
infection control problems on top of generating 
unnecessary costs [1,2,3,4]. In addition, unnecessary 
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hospital admission imposes financial and psychosocial 
burdens for TB patients. 
In Armenia over one third of TB suspects are 
referred to TB hospitals (by law, for seven days) for 
diagnosis, with only 35% of them being diagnosed 
with active TB. 
The study results demonstrate, for the first time in 
a FSU setting, the savings which can be achieved by 
decreasing the load of patients sent to hospitals for 
diagnostic purposes and increasing the proportion of 
TB patients diagnosed in TB out-patient units. 
Furthermore, the Armenian experience shows that 
no policy change in this direction can be achieved if 
health-care TB funding mechanisms are not modified. 
The per-bed daily refund scheme blocks any possible 
reform of TB admission policies [1]. 
The economic savings that such a change will 
generate could be directed to strengthen human 
resources at the primary health-care level, with 
improved quality of life for patients and reduced risk 
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Figure. Potential cost reductions and savings (in €) for each day of hospitalisation avoided in non-infectious TB cases 
(sputum smear negative and extrapulmonary) using Armenia 2011 notification rates as baseline 
 
Scenario 1: present situation; Scenario 2: 25% of non-infectious TB cases not admitted; Scenario 3: 50% of non-infectious TB cases 
not admitted; Scenario 4: 75% of non-infectious TB cases not admitted  
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